Cargando…

Research progress in delineating the pathological mechanisms of GJB2-related hearing loss

Hearing loss is the most common congenital sensory impairment. Mutations or deficiencies of the GJB2 gene are the most common genetic cause of congenital non-syndromic deafness. Pathological changes such as decreased potential in the cochlea, active cochlear amplification disorders, cochlear develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yujun, Jin, Yuan, Zhang, Qiong, Xiong, Ying, Gu, Xiang, Zeng, Shan, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272732/
https://www.ncbi.nlm.nih.gov/pubmed/37333892
http://dx.doi.org/10.3389/fncel.2023.1208406
Descripción
Sumario:Hearing loss is the most common congenital sensory impairment. Mutations or deficiencies of the GJB2 gene are the most common genetic cause of congenital non-syndromic deafness. Pathological changes such as decreased potential in the cochlea, active cochlear amplification disorders, cochlear developmental disorders and macrophage activation have been observed in various GJB2 transgenic mouse models. In the past, researchers generally believed that the pathological mechanisms underlying GJB2-related hearing loss comprised a K(+) circulation defect and abnormal ATP-Ca(2+) signals. However, recent studies have shown that K(+) circulation is rarely associated with the pathological process of GJB2-related hearing loss, while cochlear developmental disorders and oxidative stress play an important, even critical, role in the occurrence of GJB2-related hearing loss. Nevertheless, these research has not been systematically summarized. In this review, we summarize the pathological mechanisms of GJB2-related hearing loss, including aspects of K(+) circulation, developmental disorders of the organ of Corti, nutrition delivery, oxidative stress and ATP-Ca(2+) signals. Clarifying the pathological mechanism of GJB2-related hearing loss can help develop new prevention and treatment strategies.